Skip to Content

3QD (Viekira XR dasabuvir 200 mg / ombitasvir 8.33 mg / paritaprevir 50 mg / ritonavir 33.33 mg)

Generic Name: dasabuvir/ombitasvir/paritaprevir/ritonavir

Pill with imprint 3QD is Yellow, Capsule-shape and has been identified as Viekira XR dasabuvir 200 mg / ombitasvir 8.33 mg / paritaprevir 50 mg / ritonavir 33.33 mg. It is supplied by AbbVie Inc..

Viekira XR is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Viekira XR dasabuvir 200 mg / ombitasvir 8.33 mg / paritaprevir 50 mg / ritonavir 33.33 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 3QD

Viekira XR

Generic Name:
dasabuvir/ombitasvir/paritaprevir/ritonavir
Imprint:
3QD
Strength:
dasabuvir 200 mg / ombitasvir 8.33 mg / paritaprevir 50 mg / ritonavir 33.33 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
AbbVie Inc.
National Drug Code (NDC):
00074-0063

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide